Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.95 EUR | -3.55% |
|
-9.52% | -10.38% |
05-01 | Bio-Gate AG Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
2023 | Bio-Gate AG Reports Earnings Results for the Half Year Ended June 30, 2023 | CI |
Valuation
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Capitalization 1 | 6.499 | 6.499 | 29.18 | 20.78 | 8.908 | 9.101 | - | - |
Enterprise Value (EV) 1 | 6.499 | 6.499 | 29.18 | 20.78 | 8.908 | 9.101 | 9.101 | 9.101 |
P/E ratio | - | - | - | - | - | - | - | - |
Yield | - | - | - | - | - | - | - | - |
Capitalization / Revenue | 1.86 x | 1.27 x | 4.68 x | 3.47 x | 1.23 x | 1.14 x | 1 x | 0.87 x |
EV / Revenue | 1.86 x | 1.27 x | 4.68 x | 3.47 x | 1.23 x | 1.14 x | 1 x | 0.87 x |
EV / EBITDA | - | -12.4 x | -84.6 x | -13.4 x | -6.71 x | -16.9 x | -165 x | 12.5 x |
EV / FCF | - | - | -32.2 x | - | - | -10.3 x | -14.3 x | 607 x |
FCF Yield | - | - | -3.11% | - | - | -9.72% | -6.98% | 0.16% |
Price to Book | - | - | - | - | - | - | - | - |
Nbr of stocks (in thousands) | 4,304 | 4,304 | 7,639 | 7,639 | 8,403 | 9,240 | - | - |
Reference price 2 | 1.510 | 1.510 | 3.820 | 2.720 | 1.060 | 0.9850 | 0.9850 | 0.9850 |
Announcement Date | 20-06-08 | 21-04-26 | 22-04-07 | 23-04-29 | 24-05-01 | - | - | - |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net sales 1 | 3.487 | 5.132 | 6.235 | 5.99 | 7.245 | 8.005 | 9.065 | 10.49 |
EBITDA 1 | - | -0.522 | -0.345 | -1.547 | -1.327 | -0.54 | -0.055 | 0.73 |
EBIT 1 | - | -0.819 | -0.538 | -1.787 | -1.594 | -0.83 | -0.345 | 0.385 |
Operating Margin | - | -15.96% | -8.63% | -29.83% | -22% | -10.37% | -3.81% | 3.67% |
Earnings before Tax (EBT) | - | - | - | - | - | - | - | - |
Net income | -1.031 | - | - | - | - | - | - | - |
Net margin | -29.57% | - | - | - | - | - | - | - |
EPS | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -0.907 | - | - | -0.885 | -0.635 | 0.015 |
FCF margin | - | - | -14.55% | - | - | -11.06% | -7% | 0.14% |
FCF Conversion (EBITDA) | - | - | - | - | - | - | - | 2.05% |
FCF Conversion (Net income) | - | - | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - | - | - |
Announcement Date | 20-06-08 | 21-04-26 | 22-04-07 | 23-04-29 | 24-05-01 | - | - | - |
Balance Sheet Analysis
Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|---|
Net Debt | - | - | - | - | - | - | - | - |
Net Cash position | - | - | - | - | - | - | - | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
Free Cash Flow 1 | - | - | -0.91 | - | - | -0.89 | -0.64 | 0.02 |
ROE (net income / shareholders' equity) | - | - | - | - | - | - | - | - |
ROA (Net income/ Total Assets) | - | - | - | - | - | - | - | - |
Assets | - | - | - | - | - | - | - | - |
Book Value Per Share | - | - | - | - | - | - | - | - |
Cash Flow per Share | - | - | - | - | - | - | - | - |
Capex 1 | - | - | 0.27 | - | - | 0.2 | 0.5 | 0.7 |
Capex / Sales | - | - | 4.38% | - | - | 2.5% | 5.52% | 6.67% |
Announcement Date | 20-06-08 | 21-04-26 | 22-04-07 | 23-04-29 | 24-05-01 | - | - | - |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-10.38% | 9.77M | |
-7.03% | 180B | |
-6.32% | 99.21B | |
-6.15% | 66.25B | |
-10.62% | 44.74B | |
+8.34% | 43.82B | |
+10.35% | 41.96B | |
+11.64% | 28.98B | |
+16.18% | 24.07B | |
-8.87% | 23.5B |
- Stock Market
- Equities
- BIG1 Stock
- Financials Bio-Gate AG